Conference highlights include:

We are presenting Real World Analysis of Actionable Gene Fusions Identified by NGS and Correlation with IHC in 422 Patients from the Community. This study compared the gap between panTRK IHC testing and NGS fusion confirmation for NTRK or additional fusion, as patients in certain community settings may only be tested for NTRK fusions following a positive IHC screen result. Hear more about this data during the presentation.

Stop by our booth to learn more about our Partnering Solutions: Supporting innovative testing and data solutions from pre-clinical research and development through commercialization.